Publications – KalVista Pharmaceuticals

Showing 1-10 out of 11

Substantial Reduction of Hereditary Angioedema Attack Symptom Burden in the Sebetralstat Phase 3 KONFIDENT Trial

Lumry WR, Cohn DM, Bernstein JA, Audhya PK, Hao J, Smith MD, Yea CM, Riedl MA

ACAAI 2024

Patient-Reported Benefits of Early On-demand Treatment of HAE Attacks

Guilarte M, Longhurst H, van Kooten S, Malloy N, Heckmann M, Busse P

ACARE Global Angioedema Forum 2024 (GAF)

Advent of oral medications for the treatment of hereditary angioedema

Valerieva A, Caballero T, Magerl M, Frade JP, Audhya PK, Craig PK

Clinical and Translational Allergy

Unmet Needs Associated with Non-androgen Injectable Long-term Prophylaxis (LTP) Therapies for HAE

Lumry W, Baptist A, Soteres D, Manning M, Wynne-Cattanach K, Birija L, Audhya PK, Wang A, Andriotti T, Desai V
EAACI 2024

Trends in Volume of On-demand Hereditary Angioedema Treatments in the US: A Retrospective Analysis of a Large Multi-payer Claims Database

Soteres DF, Maheshwari C, Sharma A, Wang A, Audhya PK, Tachdjian R
EAC 2024

Real-world Impact of Treated Hereditary Angioedema Attacks on Patients’ Employment and Work Productivity

Craig T, Busse P, Christiansen S, O’Connor M, Radojicic C, Ulloa J, Danese S, Andriotti T, Audhya P, Desai V
EAC 2024

Healthcare Costs Among Commercially-Insured Patients with Hereditary Angioedema Managed with Long-Term Prophylaxis: A Retrospective US Claims Database Analysis

Tachdjian R, Soteres D, Chang R, Mohan M, Pinaire M, DerSarkissian M, Desai V, Wang A, Audhya P
EAC 2024

Burden of Untreated Hereditary Angioedema Attacks and its Impact on Social, Mental, and Physical Health

Radojicic C, Busse P, Maeve O’Connor3, Ulloa J, Danese S, Desai V,Andriotti T, Audhya P, Christiansen S
EAC 2024

Healthcare Costs Among Commercially-Insured Patients with Hereditary Angioedema Managed with Long-Term Prophylaxis: A Retrospective US Claims Database Analysis

Tachdjian R, Soteres D, Chang R, Mohan M, Pinaire M, DerSarkissian M, Desai V, Wang A, Audhya P

ISPOR 2024

Characterizing the Perspective of Patients with HAE on Prophylactic Treatment (#260)

Stephen Betschel, Cristine Radojicic, Sally van Kooten, Neil Malloy, Markus Heckmann, Julie Ulloa, William Lumry

AAAAI 2024

About

Science

Pipeline

Careers

Contact